Navigation Links
Global Health Ventures to Present Live, Online at RetailInvestorConferences.com on August 4th
Date:8/1/2011

NEW YORK, Aug. 1, 2011 /PRNewswire/ -- Global Health Ventures Inc. (OTCBB: GHLV), a specialty pharmaceutical company with focus on sublingual drug delivery announced today that Dr. Hassan Salari PhD, Chairman and CEO will be presenting at RetailInvestorConferences.com.

DATE:  August 4, 2011
TIME:  7:00pm EDT
LINK:  www.retailinvestorconferences.com>Click the red "register/ watch event now" button.

This will be a live, interactive online event where investors are invited to ask the company questions in real-time both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live in real-time, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About Global Health Ventures

Global Health Ventures (GHLV.OB) is a specialty pharmaceutical company with expertise in drug delivery and formulation. The Company has developed a new formulation for drug delivery via the sublingual (under the tongue) route. This unique method delivers drugs to the bloodstream quickly with less drug breakdown in the liver or gastrointestinal system, a process that can reduce side effects associated with the drugs. The Company's lead therapeutic product is a male sexual enhancement drug that is delivered via sublingual route and is called X-Excite. In human studies, X-Excite has been shown to reach the blood stream faster than the oral route of delivery. The Company's second drug "Relax-B" is also under development in Canada for anxiety. And, the third drug will be an anti-migraine drug. The Company plans to use the same technology to deliver a vast number of other FDA approved drugs that require faster delivery, or reduced hepatic and gastrointestinal side effects. These include anti-stress, sleeping disorders, pain killers, anti-allergy medications, heart and lung medication, migraine and addiction replacement therapies. 

About RetailInvestorConferences.com:

RetailInvestorConferences.com, created by BetterInvesting (NAIC), PR Newswire and MUNCmedia, is the first monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.


'/>"/>
SOURCE Global Health Ventures
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... Research and Markets has announced the ... to 2022" report to their offering. ... An increasing number ... rising adoption of tension free repair procedures and increasing demand ... repair devices global market. However, Inconsistent reimbursement and the high ...
(Date:2/20/2017)... The global  cerebral spinal ... USD 1.4 billion by 2022, according to a ... evaluation of various techniques by neurosurgeons for improvement ... in this market. Moreover, shunt manufacturers are engaged ... improved shunts in order to tackle the pitfalls ...
(Date:2/19/2017)... ORLANDO, Fla. , Feb. 19, 2017 /PRNewswire/ ... its revenue cycle portfolio and thought leadership at ... be receiving a category leader award from KLAS. ... Learn panel discussion focused on how market trends ... future -  particularly a sophisticated, comprehensive Patient Access ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... ... The Citadel’s new Swain Department of Nursing , along with its ... Joseph was engaged by the college as a consultant to help build the curriculum ... nation-wide search, she was selected to head the department as nurse administrator, assuming the ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... **FDAnews Free Webinar**, March 1, 2017 — 1:30 p.m. – 2:30 p.m. ... burden? Pay dividends in enhanced and predictable product performance? Streamline processes resulting ...
(Date:2/18/2017)... ... 18, 2017 , ... ProParagraph Fashion Volume 2 features 30 ... Fashion Volume 2 for all multi-line FCPX project needs. Great for website ... choose from hand-crafted trend-setting designs with smooth animations that will add stylistic flare ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... allow for the electronic prescribing of controlled and non-controlled substances plus the ability ... of pharmacies in the United States now accept electronic prescriptions, according to the ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... organizations, has been named a finalist in the 8th Annual DecisionHealth Platinum Awards ... healthcare delivery system. Qualis Health’s work is recognized across multiple award categories, highlighting ...
Breaking Medicine News(10 mins):